Overview - The company Varonis focuses on data security, emphasizing that cybersecurity is fundamentally about protecting data rather than physical assets [2]. Industry Context - The cybersecurity landscape is increasingly complex, with companies managing vast amounts of data across data centers and various cloud platforms, including hyperscalers and AI workloads [2]. - Companies face significant regulatory risks regarding data management, including questions about data inventory, location, and control measures [2]. - There is a growing reputational risk for companies, as data breaches can lead to negative publicity and loss of trust, exemplified by the potential for being featured in major news outlets like the Wall Street Journal [2].

Core Insights - Willis, a WTW business, has launched a Reputational Risk Quantification Model specifically for celebrity endorsements, utilizing extensive datasets from Polecat to assess reputational risks associated with celebrity endorsers and brand ambassadors [1][3]. Industry Overview - The Global Reputational Risk Readiness Survey 2024/25 indicates that 99% of companies consider reputation among their top 10 risks, with notable sectors including Leisure and Hospitality (53%), Retail (43%), Manufacturing (51%), Transportation (34%), and NGOs/Charities (48%) ranking it in their top five [2]. Model Features - The new model employs advanced risk analytics and real-time intelligence from Polecat to evaluate the potential impact on sales and profits in scenarios where celebrity endorsers face reputational damage, providing brands with data-driven insights for better decision-making and proactive risk management [4]. Expert Commentary - James Gillespie, Head of Data & Analytics at Willis, emphasized that reputation is increasingly viewed as an asset class, and the model transforms subjective judgments into quantifiable insights, allowing clients to understand the financial implications of celebrity endorsements [5]. - James Lawn, CEO at Polecat, noted that the model enables organizations to quantify previously intangible reputational risks, enhancing their ability to manage these risks effectively [5]. Upcoming Events - Willis will host a Reputational Risk Roundtable event on February 26, 2026, aimed at senior executives and risk professionals, focusing on the new Celebrity endorsement feature and discussing various aspects of managing reputation risks [5].

Core Viewpoint - Kenvue faces significant regulatory and reputational challenges due to unsubstantiated claims linking acetaminophen to autism during pregnancy, which threatens its Self-Care segment revenue [1][2] Company Overview - Kenvue, a consumer health company spun off from Johnson & Johnson in 2023, is defending the safety of acetaminophen, asserting that over a decade of research shows no credible evidence linking it to autism [2] - The company has experienced a market capitalization of $34 billion, but its stock has declined approximately 20% in 2025 due to concerns over market share erosion and litigation risks [4] Financial Performance - In Q2 of 2025, Kenvue reported a 4.2% decline in organic sales, with adjusted earnings narrowing from $0.32 per share to $0.29 per share over the last 12 months [5] Leadership Changes - Recent leadership changes, including the appointment of interim CEO Kirk Perry, who has over 30 years of experience in consumer packaged goods and technology, provide cautious optimism for the company's future [6] - The new leadership indicates a strategic pivot towards operational excellence and consumer-centric execution [6]

The gentleman from Wisconsin, Mr. . Style, who's also the chair of our subcommittee on digital assets, financial technology, and artificial intelligence. You're recognized for five minutes.Thank you, Chairman Hill. Thank you, Chairman Powell, for being with us today. I want to dive into two actions the Fed's recently taken uh to get a little additional color on.Yesterday, uh the Fed announced uh that reputational risk would no longer be a component in bank exams. Uh I viewed that positively. I viewed u the ...